ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?

Research output: Contribution to journalComment/debate

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)564-566
Number of pages3
JournalCancer Biology and Therapy
Volume10
Issue number6
DOIs
StatePublished - Sep 15 2010

Keywords

  • Drug resistance
  • EGFR
  • ERBB3
  • Erlotinib
  • HER3
  • Pancreatic cancer

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this